CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Vice President-Finance & CFO acquired 70,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 100,000 shares
- 4 Open-market buy Director bought 100,000 shares
- 4 Open-market buy Chief Operating Officer bought 800,000 shares
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion VP-Finance & CFO acquired 5,000 shares (option exercise)
- 4 Open-market buy Director bought 100,000 shares at an average $0.28 ($28,085)
- 4 Open-market buy Director bought 105,000 shares at an average $0.29 ($30,150)
Page 17 of 24 · 471 filings